LAKE FOREST, Ill., Dec. 19, 2014 /PRNewswire/ -- Hospira, Inc.
(NYSE: HSP), the world's leading provider of injectable drugs and
infusion technologies, today announced that the company will
present at the J.P. Morgan 33rd Annual Healthcare Conference on
Wednesday, Jan. 14, 2015, in
San Francisco.
The presentation is scheduled to begin at 10:30 a.m. Pacific time on Wednesday, Jan. 14, 2015. It will be
available to all interested parties through a live audiocast
accessible via the Investor Relations section of Hospira's website
at www.hospirainvestor.com. Listeners should log on approximately
10 minutes in advance to ensure proper setup to receive the
audiocast. The slides accompanying the presentation will be
available on the Hospira website. A replay of the webcast will be
available on the Hospira website approximately 24 hours after the
live presentation for 30 days after the event.
About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs
and infusion technologies, and a global leader in biosimilars.
Through its broad, integrated portfolio, Hospira is uniquely
positioned to Advance Wellness™ by improving patient and caregiver
safety while reducing healthcare costs. The company is
headquartered in Lake Forest,
Ill., and has approximately 19,000 employees. Learn more at
www.hospira.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hospira-to-present-at-the-jp-morgan-33rd-annual-healthcare-conference-jan-14-2015-300012702.html
SOURCE Hospira, Inc.